Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

about

Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD).

P2860

Q40128143-F51539E2-B75A-4985-87F3-3420D3B7A646

P2860

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

Item

http://www.wikidata.org/entity/Q41605464

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Switching from zidovudine/lami ...... as measured by fat mass ratio.

@en

type

Item

label

Switching from zidovudine/lami ...... as measured by fat mass ratio.

@en

prefLabel

Switching from zidovudine/lami ...... as measured by fat mass ratio.

@en

P1476

Switching from zidovudine/lami ...... as measured by fat mass ratio

@en

P2093

B Clotet

http://www.w3.org/2001/XMLSchema#string

E Martínez

http://www.w3.org/2001/XMLSchema#string

J Berenguer

http://www.w3.org/2001/XMLSchema#string

J Sanz

http://www.w3.org/2001/XMLSchema#string

M L Álvarez

http://www.w3.org/2001/XMLSchema#string

M Larrousse

http://www.w3.org/2001/XMLSchema#string

P Ferrer

http://www.w3.org/2001/XMLSchema#string

R Rubio

http://www.w3.org/2001/XMLSchema#string

S Arterburn

http://www.w3.org/2001/XMLSchema#string

P2860

Dual energy X-Ray absorptiometry body composition reference values from NHANES

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.

Fat distribution in men with HIV infection.

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy.

Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy.

Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.

P304

370-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12210

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25496141

http://www.w3.org/2001/XMLSchema#string

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

about

P2860

P2860

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698